US$ 22.51
glp 1 drugs news Medicare will now help pay for some GLP-1 drugs. Here's what to know Weight loss drugs and addiction:
Description
Product Type Analysis The semaglutide segment led in 2024, claiming a market share of 58.4% owing to the clinical efficacy and widespread adoption of semaglutide-based products for both type 2 diabetes and obesity management

Factors that negatively affected growth in the historic period were high discontinuation rates due to GI side effects and rising competition from alternative therapies

Mol Metab 18, 314 (2018)

Semaglutide GLP-1 can increase the risk of MTC, which is a rare type of thyroid cancer

For instance, according to the International Diabetes Federation Diabetes Atlas (2021 edition), China and India were estimated to have 140.9 million and 74.2 million adults with diabetes in 2021, and these numbers are projected to increase to 174.4 million and 124.9 million, respectively, by 2045
Its convenience and efficacy make it a popular choice for those seeking significant results